Inflammatory Bowel Disease (IBD) Crohn'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 to 70 years, 2.IBD Group: Confirmed CD or UC diagnosis duration more than or equal to 6 months, 3.Control Group: No history of IBD, chronic inflammation, or established cardiovascular disease, 4.Ability to provide written informed consent
Exclusion criteria
Exclusion criteria: 1.Established clinical ASCVD (e.g., MI, stroke), 2.Current or former smokers with a smoking history of more than 5 pack-years, 3.Current or prior use of statin therapy, 4.Hypertension (>140/90 mmHg or medication use), 5.Diabetes mellitus, 6.BMI more than or equal to 30 kg per metersquare, 7.Significant systemic autoimmune diseases (e.g., RA, SLE), 8.Chronic kidney disease (eGFR < 60).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean common carotid intima-media thickness (CIMT) During ultrasound assessment Measurement of the distal common carotid artery far wall using high-resolution B-mode ultrasound (mm) | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of carotid atherosclerotic plaques During ultrasound assessment(Cross-sectional assessment) Focal atherosclerotic lesions identified during systematic interrogation,Correlation between CIMT and inflammatory markers During ultrasound assessment(Cross-sectional assessment) High-sensitivity C-reactive protein (hsCRP),Peak Systolic Velocity (PSV), End-Diastolic Velocity (EDV), and Resistive Index (RI) During ultrasound assessment(Cross-sectional assessment) N/A | — |
Countries
Thailand
Contacts
Department of Medicine, Faculty of Medicine, Khon Kaen University